English  |  正體中文  |  简体中文  |  2819016  
???header.visitor??? :  28406959    ???header.onlineuser??? :  450
???header.sponsordeclaration???
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
???ui.leftmenu.abouttair???

???ui.leftmenu.bartitle???

???index.news???

???ui.leftmenu.copyrighttitle???

???ui.leftmenu.link???

"hong r l"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1??? ???jsp.browse.items-by-author.order2???

Showing items 116-140 of 239  (10 Page(s) Totally)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2021-03-18T02:03:53Z Expression of CD44 and its clinical implication in diffuse-type and intestinal-type gastric adenocarcinomas Hong R.-L.; Lee W.-J.; CHIA-TUNG SHUN; Chu J.-S.; Chen Y.-C.
臺大學術典藏 2021-03-18T02:03:40Z Overexpression of p53 predicts shorter survival in diffuse type gastric cancer Lee W.-J.; CHIA-TUNG SHUN; Hong R.-L.; Wu M.-S.; Chang K.-J.; Chen K.-M.
臺大學術典藏 2021-03-18T02:03:28Z Alterations of BAT-26 identify a subset of gastric cancer with distinct clinicopathologic features and better postoperative prognosis Wu M.-S.; Lee C.-W.; Sheu J.-C.; CHIA-TUNG SHUN; Wang H.-P.; Hong R.-L.; Lee W.-J.; Lin J.-T.
臺大學術典藏 2021-03-15T06:27:34Z Factors impacting prognosis prediction in BCLC stage C and Child-Pugh Class A hepatocellular carcinoma patients in prospective clinical trials of systemic therapy Lin Z.-Z.; Hsu C.; Hu F.-C.; Shao Y.-Y.; DWANG-YING CHANG; Yang C.-H.; Hong R.-L.; Hsu C.-H.; Chengb A.-L.
臺大學術典藏 2021-03-12T02:29:12Z Late survival of non-small cell lung cancer patients with brain metastases: Influence of treatment Chang D.-B.; Yang P.-C.; Luh K.-T.; Kuo S.-H.; Hong R.-L.; LI-NA LEE
臺大學術典藏 2021-03-09T05:18:39Z Difference in the incidence trend of nasopharyngeal and oropharyngeal carcinomas in Taiwan: Implication from age-period-cohort analysis Hsu C.; Ying-Chun Shen; Cheng C.-C.; Hong R.-L.; Chang C.-J.; Cheng A.-L.
臺大學術典藏 2021-03-04T02:36:03Z Response of refractory osteosarcoma to thalidomide and celecoxib Yu-Chieh Tsai;Wu C.-T.;Hong R.-L.; YU-CHIEH TSAI; Wu C.-T.; Hong R.-L.
臺大學術典藏 2021-02-23T08:26:31Z Postoperative intensity-modulated radiotherapy for squamous cell carcinoma of the external auditory canal and middle ear: Treatment outcomes, marginal misses, and perspective on target delineation Chen W.-Y.; SUNG-HSIN KUO; Chen Y.-H.; Lu S.-H.; Tsai C.-L.; Chia-Hsien Cheng J.; Hong R.-L.; Chen Y.-F.; Hsu C.-J.; Lin K.-N.; Ko J.-Y.; Lou P.-J.; Wang C.-P.; Chong F.-C.; Wang C.-W.
臺大學術典藏 2021-02-23T08:26:30Z Intensity-modulated radiation therapy for T4 nasopharyngeal carcinoma: Treatment results and locoregional recurrence Chen J.L.-Y.; Huang Y.-S.; SUNG-HSIN KUO; Chen Y.-F.; Hong R.-L.; Ko J.-Y.; Lou P.-J.; Tsai C.-L.; Chen W.-Y.; Wang C.-W.
臺大學術典藏 2021-02-23T08:26:20Z Treatment outcomes of and prognostic factors for definitive radiotherapy with and without chemotherapy for Stage I/II nasal extranodal NK/T-cell lymphoma Yang C.W.-C.;Wang C.-W.;Hong R.-L.;Tsai C.-L.;Yao M.;Tang J.-L.;Lin C.-W.;Cheng A.-L.;Sung-Hsin Kuo; Yang C.W.-C.; Wang C.-W.; Hong R.-L.; Tsai C.-L.; Yao M.; Tang J.-L.; Lin C.-W.; Cheng A.-L.; SUNG-HSIN KUO
臺大學術典藏 2021-02-23T08:26:19Z Intensity-modulated radiation therapy achieves better local control compared to three-dimensional conformal radiation therapy for T4-stage nasopharyngeal carcinoma Chen J.L.;Huang Y.-S.;Sung-Hsin Kuo;Hong R.-L.;Ko J.-Y.;Lou P.-J.;Wang C.-W.; Chen J.L.; Huang Y.-S.; SUNG-HSIN KUO; Hong R.-L.; Ko J.-Y.; Lou P.-J.; Wang C.-W.
臺大學術典藏 2021-02-23T08:26:14Z Prognostic factors and treatment outcomes of adult patients with rhabdomyosarcoma after multimodality treatment Liu Y.-T.;Wang C.-W.;Hong R.-L.;Sung-Hsin Kuo; Liu Y.-T.; Wang C.-W.; Hong R.-L.; SUNG-HSIN KUO
臺大學術典藏 2021-02-02T02:24:43Z Overexpression of p53 predicts shorter survival in diffuse type gastric cancer Lee W.-J.; Shun C.-T.; Hong R.-L.; MING-SHIANG WU; Chang K.-J.; Chen K.-M.
臺大學術典藏 2021-02-02T02:22:32Z Alterations of BAT-26 identify a subset of gastric cancer with distinct clinicopathologic features and better postoperative prognosis MING-SHIANG WU; Lee C.-W.; Sheu J.-C.; Shun C.-T.; Wang H.-P.; Hong R.-L.; Lee W.-J.; Lin J.-T.
臺大學術典藏 2021-02-02T00:47:13Z Use of retinoic acids in the treatment of peripheral T-cell lymphoma: A pilot study Cheng A.-L.; Su I.-J.; Chen C.-C.; Tien H.-F.; Lay J.-D.; Chen B.-R.; YEONG-SHIAU PU; Hong R.-L.; Shen M.-C.; Wang C.-H.; Chen Y.-C.
臺大學術典藏 2021-02-02T00:47:12Z Expressions of E-Cadherin and Exon V6-Containing Isoforms of CD44 and their Prognostic Values in Human Transitional Cell Carcinoma Hong R.-L.;Yeong-Shiau Pu;Hsieh T.-S.;Chu J.-S.;Lee W.-J.; Hong R.-L.; YEONG-SHIAU PU; Hsieh T.-S.; Chu J.-S.; Lee W.-J.
臺大學術典藏 2021-02-02T00:47:11Z Correlation of expression of CD44 isoforms and E-cadherin with differentiation in human urothelial cell lines and transitional cell carcinoma Hong R.-L.;Yeong-Shiau Pu;Chu J.-S.;Lee W.-J.;Chen Y.-C.;Wu C.-W.; Hong R.-L.; YEONG-SHIAU PU; Chu J.-S.; Lee W.-J.; Chen Y.-C.; Wu C.-W.
臺大學術典藏 2021-01-28T01:07:01Z MVP (mitomycin-C, vinblastine, cisplatin) salvage chemotherapy for relapsed and refractory metastatic breast cancer Hsu C.;Kun-Huei Yeh;Hong R.-L.;Yang C.-H.;Lin M.-T.;Chen Y.-C.;Cheng A.-L.; Hsu C.; KUN-HUEI YEH; Hong R.-L.; Yang C.-H.; Lin M.-T.; Chen Y.-C.; Cheng A.-L.
臺大學術典藏 2021-01-28T01:07:00Z A phase II study of weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin (HDFL) in the treatment of recurrent or metastatic colorectal cancers Kun-Huei Yeh;Cheng A.-L.;Lin M.-T.;Hong R.-L.;Hsu C.-H.;Lin J.-F.;Chang K.-J.;Lee P.-H.;Chen Y.-C.; KUN-HUEI YEH; Cheng A.-L.; Lin M.-T.; Hong R.-L.; Hsu C.-H.; Lin J.-F.; Chang K.-J.; Lee P.-H.; Chen Y.-C.
臺大學術典藏 2021-01-15T03:47:58Z Alterations of BAT-26 identify a subset of gastric cancer with distinct clinicopathologic features and better postoperative prognosis Wu M.-S.; Lee C.-W.; Sheu J.-C.; Shun C.-T.; HSIU-PO WANG; Hong R.-L.; Lee W.-J.; Lin J.-T.
臺大學術典藏 2021-01-12T12:49:22Z Reduction of leukocyte count is associated with thalidomide response in treatment of multiple myeloma SHANG-YI HUANG; Tang J.-L.; Yao M.; Ko B.-S.; Hong R.-L.; Tsai W.; Wang C.-H.; Tien H.-F.; Shen M.-C.; Chen Y.-C.
臺大學術典藏 2021-01-06T03:58:54Z Treatment Outcome and Pattern of Failure in 77 Patients with Sinonasal Natural Killer/T-Cell or T-Cell Lymphoma Li C.-C.; Tien H.-F.; JIH-LUH TANG; Yao M.; Chen Y.-C.; Su I.-J.; Hsu S.-M.; Hong R.-L.
臺大學術典藏 2021-01-06T03:58:54Z Reduction of leukocyte count is associated with thalidomide response in treatment of multiple myeloma Huang S.-Y.; JIH-LUH TANG; Yao M.; Ko B.-S.; Hong R.-L.; Tsai W.; Wang C.-H.; Tien H.-F.; Shen M.-C.; Chen Y.-C.
臺大學術典藏 2021-01-06T03:58:26Z Treatment outcomes of and prognostic factors for definitive radiotherapy with and without chemotherapy for Stage I/II nasal extranodal NK/T-cell lymphoma Wang C.-W.; Hong R.-L.; Tsai C.-L.; Yao M.; JIH-LUH TANG; Lin C.-W.; Cheng A.-L.; Kuo S.-H.; Yang C.W.-C.
臺大學術典藏 2021-01-05T03:35:00Z Reduction of leukocyte count is associated with thalidomide response in treatment of multiple myeloma Tien H.-F.; Wang C.-H.; Hong R.-L.; Tsai W.; Ko B.-S.; MING YAO; Tang J.-L.; Huang S.-Y.; Shen M.-C.; Chen Y.-C.

Showing items 116-140 of 239  (10 Page(s) Totally)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
View [10|25|50] records per page